Market Closed -
Other stock markets
|
Pre-market 07:00:19 am | |||
417.3 USD | -0.27% | 419.5 | +0.52% |
Mar. 21 | Vertex Pharmaceuticals Gets FDA Approval for VX-407's Investigational New Drug Application to Treat Kidney Disease | MT |
Mar. 21 | Vertex Gets FDA OK to Study VX-407 in Genetic Kidney Disease | DJ |
Filters
- Stock
- Equities
- Stock Vertex Pharmaceuticals Incorporated - Nasdaq
- News Vertex Pharmaceuticals Incorporated